Center for Scientific Review; Notice of Closed Meetings, 67554-67555 [2020-23469]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
67554
Federal Register / Vol. 85, No. 206 / Friday, October 23, 2020 / Notices
On January 9, 2020, Mr. Carawan was
convicted as defined in section
306(l)(1)(B) of the FD&C Act, in the U.S.
District Court for the Eastern District of
North Carolina, when the court accepted
Mr. Carawan’s plea of guilty and entered
judgment against him for the offense of
violating the Lacey Act and Aiding and
Abetting. This offense was in violation
of 16 U.S.C. 3372(d)(1) and
3373(d)(3)(A)(j) and 18 U.S.C. 2.
FDA’s finding that the debarment is
appropriate is based on the felony
conviction referenced herein. The
factual basis for this conviction is as
follows: As contained in the Indictment,
filed on June 26, 2019, Mr. Carawan
served as the owner and operator, and
acted as the President and Chief
Executive Officer, of Capt. Neill’s
Seafood, Inc. (Capt. Neill’s). Capt.
Neill’s is a North Carolina corporation
in the business of purchasing,
processing, packaging, transporting, and
selling seafood and seafood products,
including crab meat from domestically
harvested Atlantic blue crab, and
products made from Atlantic blue crab.
From as early as January 1, 2012 and
continuing through December 31, 2015,
Mr. Carawan caused Capt. Neill’s to
purchase foreign crab meat from South
American and Asia. Mr. Carawan
directed Capt. Neill’s employees to
repackage the foreign crab meat into
containers labeled ‘‘Product of USA.’’
Mr. Carawan then knowingly caused
those containers of foreign crab meat to
be sold as jumbo domestically harvested
blue crab to customers. During the
relevant time frame, Mr. Carawan
caused the sale of approximately
200,536 pounds of crab meat falsely
labeled ‘‘Product of USA’’ with a total
retail market value of $4,082,841.
As a result of this conviction FDA
sent Mr. Carawan, by certified mail on
May 6, 2020, a notice proposing to debar
him for a period of 5 years from
importing articles of food or offering
such articles for import into the United
States. The proposal was based on a
finding under section 306(b)(1)(C) of the
FD&C Act that Mr. Carawan’s felony
conviction of violating the Lacey Act
and Aiding and Abetting in violation of
16 U.S.C. 3372(d)(1) and 3373(d)(3)(A)(j)
and 18 U.S.C 2, constitutes conduct
relating to the importation into the
United States of an article of food
because the offense involved Mr.
Carawan aiding and abetting the
importation of foreign crab meat to be
falsely labeled as ‘‘Product of USA.’’
The proposal was also based on a
determination, after consideration of the
relevant factors set forth in section
306(c)(3) of the FD&C Act, that Mr.
Carawan should be subject to a 5-year
VerDate Sep<11>2014
18:09 Oct 22, 2020
Jkt 253001
period of debarment. The proposal also
offered Mr. Carawan an opportunity to
request a hearing, providing Mr.
Carawan 30 days from the date of
receipt of the letter in which to file the
request, and advised Mr. Carawan that
failure to request a hearing constituted
a waiver of the opportunity for a hearing
and of any contentions concerning this
action. Mr. Carawan failed to respond
within the timeframe prescribed by
regulation and has, therefore, waived
his opportunity for a hearing and
waived any contentions concerning his
debarment (21 CFR part 12).
II. Findings and Order
Therefore, the Assistant
Commissioner, Office of Human and
Animal Food Operations, under section
306(b)(1)(C) of the FD&C Act, under
authority delegated to the Assistant
Commissioner, finds that Mr. Carawan
has been convicted of a felony count
under Federal law for conduct relating
to the importation into the United States
of an article of food and that he is
subject to a 5-year period of debarment.
As a result of the foregoing finding,
Mr. Carawan is debarred for a period of
5 years from importing articles of food
or offering such articles for import into
the United States, effective (see DATES).
Pursuant to section 301(cc) of the FD&C
Act (21 U.S.C. 331(cc)), the importing or
offering for import into the United
States of an article of food by, with the
assistance of, or at the direction of
Phillip R. Carawan is a prohibited act.
Any application by Mr. Carawan for
termination of debarment under section
306(d)(1) of the FD&C Act should be
identified with Docket No. FDA–2020–
N–0861 and sent to the Dockets
Management Staff (see ADDRESSSES). All
such submissions are to be filed in four
copies. The public availability of
information in these submissions is
governed by 21 CFR 10.20.
Publicly available submissions will be
placed in the docket, and will be
viewable at https://www.regulations.gov
or at the Dockets Management Staff (see
ADDRESSES) between 9 a.m. and 4 p.m.
Eastern time, Monday through Friday.
Dated: October 19, 2020.
Lauren K. Roth,
Acting Principal Associate Commissioner for
Policy.
[FR Doc. 2020–23501 Filed 10–22–20; 8:45 am]
BILLING CODE 4164–01–P
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cardiovascular Sciences.
Date: November 17, 2020.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sara Ahlgren, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, RM 4136,
Bethesda, MD 20892, 301–435–0904,
sara.ahlgren@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Innate Immunity, Host Defense and
Vaccines.
Date: November 18, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Deborah Hodge, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4207,
MSC 7812, Bethesda, MD 20892, (301) 435–
1238, hodged@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Vascular and Hematology.
Date: November 18, 2020.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Larry Pinkus, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4132,
MSC 7802, Bethesda, MD 20892, (301) 435–
1214, pinkusl@csr.nih.gov.
E:\FR\FM\23OCN1.SGM
23OCN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 85, No. 206 / Friday, October 23, 2020 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Improving Animal Models of Influenza
Infection That Are Predictive of Human
Immunity and Vaccination.
Date: November 18, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth M. Izumi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3204,
MSC 7808, Bethesda, MD 20892, (301) 496–
6980, izumikm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: The Cancer Drug Development &
Therapeutics (CDDT).
Date: November 19–20, 2020.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lilia Topol, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, 301–451–
0131, ltopol@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Drug Discovery for Aging,
Neuropsychiatric and Neurologic Disorders.
Date: November 19–20, 2020.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Aurea D. De Sousa, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Room 5186, Bethesda, MD
20892, 301–827–6829, aurea.desousa@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–19–
367: Maximizing Investigators’ Research
Award (R35—Clinical Trial Optional).
Date: November 19–20, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas Beres, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 5201,
MSC 7840, Bethesda, MD 20892, 301–435–
1175, berestm@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Biological Chemistry, Biophysics,
and Assay Development.
Date: November 19–20, 2020.
Time: 9:00 a.m. to 5:00 p.m.
VerDate Sep<11>2014
18:09 Oct 22, 2020
Jkt 253001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John Harold Laity, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 301–402–8254,
john.laity@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Clinical Neurophysiology, Devices,
Neuroprosthetics, and Biosensors.
Date: November 19–20, 2020.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Cristina Backman, Ph.D.,
Scientific Review Officer, ETTN IRG Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5211,
MSC 7846, Bethesda, MD 20892, 301–480–
9069, cbackman@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Health Informatics.
Date: November 19–20, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Weijia Ni, Ph.D., Chief/
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3100,
MSC 7808, Bethesda, MD 20892, 301–594–
3292, niw@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Neuro/Psychopathology, Lifespan
Development, and STEM Education.
Date: November 19–20, 2020.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elia K. Ortenberg, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108,
MSC 7816, Bethesda, MD 20892, (301) 827–
7189, femiaee@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 19, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–23469 Filed 10–22–20; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
67555
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Digestive
Sciences Small Business Activities.
Date: November 19–20, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Santanu Banerjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 2106,
Bethesda, MD 20892, (301) 435–5947,
banerjees5@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; HD21–007:
Development of Fertility Regulation Methods
by Small Business.
Date: November 19, 2020.
Time: 10:00 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yunshang Piao, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 6184,
Bethesda, MD 20892, (301) 402–8402,
piaoy3@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 20–
101: Genomic Expert Curation Panels.
Date: November 20, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Baishali Maskeri, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2022,
Bethesda, MD 20892, (301) 827–2864,
maskerib@mail.nih.gov.
E:\FR\FM\23OCN1.SGM
23OCN1
]]>Agencies
[Federal Register Volume 85, Number 206 (Friday, October 23, 2020)]
[Notices]
[Pages 67554-67555]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23469]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cardiovascular Sciences.
Date: November 17, 2020.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sara Ahlgren, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, RM 4136, Bethesda, MD 20892, 301-435-0904,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Innate Immunity, Host Defense and Vaccines.
Date: November 18, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Deborah Hodge, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4207, MSC 7812, Bethesda, MD 20892, (301) 435-
1238, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Vascular and Hematology.
Date: November 18, 2020.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Larry Pinkus, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4132, MSC 7802, Bethesda, MD 20892, (301) 435-
1214, [email protected].
[[Page 67555]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Improving Animal Models of Influenza Infection
That Are Predictive of Human Immunity and Vaccination.
Date: November 18, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth M. Izumi, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3204, MSC 7808, Bethesda, MD
20892, (301) 496-6980, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: The Cancer Drug Development & Therapeutics
(CDDT).
Date: November 19-20, 2020.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lilia Topol, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301-451-
0131, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Drug Discovery for Aging, Neuropsychiatric
and Neurologic Disorders.
Date: November 19-20, 2020.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aurea D. De Sousa, Ph.D., Scientific Review
Officer, National Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Room 5186, Bethesda, MD 20892, 301-
827-6829, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-19-367: Maximizing Investigators' Research Award (R35--
Clinical Trial Optional).
Date: November 19-20, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas Beres, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Rm. 5201, MSC 7840, Bethesda, MD 20892, 301-435-
1175, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Biological Chemistry, Biophysics, and Assay
Development.
Date: November 19-20, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John Harold Laity, Ph.D., Scientific Review
Officer, Center for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 301-402-8254, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Clinical Neurophysiology, Devices,
Neuroprosthetics, and Biosensors.
Date: November 19-20, 2020.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Cristina Backman, Ph.D., Scientific Review
Officer, ETTN IRG Center for Scientific Review, National Institutes
of Health, 6701 Rockledge Drive, Room 5211, MSC 7846, Bethesda, MD
20892, 301-480-9069, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Health Informatics.
Date: November 19-20, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Weijia Ni, Ph.D., Chief/Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3100, MSC 7808, Bethesda, MD
20892, 301-594-3292, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Neuro/Psychopathology, Lifespan Development,
and STEM Education.
Date: November 19-20, 2020.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elia K. Ortenberg, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108, MSC 7816, Bethesda, MD
20892, (301) 827-7189, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 19, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-23469 Filed 10-22-20; 8:45 am]
BILLING CODE 4140-01-P
